Industries > Pharma > World Cancer-Treating Drugs Market Forecast 2017-2027

World Cancer-Treating Drugs Market Forecast 2017-2027

Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs

PUBLISHED: 14 September 2017
PAGES: 146
PRODUCT CODE: PHA0236

Clear
WOOCS 2.2.1
SKU: PHA0236 Categories: , , Tag:

The world cancer-treating drugs market is expected to grow at a CAGR of 6.6% in the second half of the forecast period. The market reached $102bn in 2016, dominated by the immunotherapy segment which held 44.1% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 194-page report you will receive 110 tables and 101 figures – all unavailable elsewhere.

The 194-page report provides clear detailed insight into the world cancer-treating drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

World cancer-treating drugs market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the world cancer-treating drugs market by its leading segments:
– Immunotherapy
– Chemotherapy
– Targeted Therapy
– Hormone Therapy

Each sector is analysed and revenue forecasts presented.

• This report discusses and forecasts revenues of the top 25 anti-cancer drugs:
– Avastin
– Herceptin
– Rituxan
– Gleevec
– Revlimid
– Alimta
– Velcade
– Erbitux
– Gardasil
– Zytiga
– Xeloda
– Tarceva
– Afinitor
– Sprycel
– Tasigna
– Sutent
– Nexavar
– Xgeva
– Zoladex
– Yervoy
– Vidaza
– Treanda
– Temodar
– Faslodex
– Abraxane
– Others

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– North America: US, Canada, Mexico
– South America: Brazil, Argentina, Paraguay, Brazil, Rest of South America
– Europe: The UK, Germany, France, Spain, Italy, Rest of Europe
– Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
– Rest of World: Middle East, Africa, Other Countries

• This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT). It also analyses social, technological, economic and political factors (STEP) that influence the cancer-treating drugs market

World Cancer-Treating Drugs Market Forecast 2017-2027

• Our study discusses the selected leading companies that are the major players in the cancer-treating drugs market:
– AstraZeneca
– Merck & Co., Inc. (Merck)
– Novartis
– Amgen
– Bristol-Myers Squibb (BMS)
– GlaxoSmithKline (GSK)
– Johnson & Johnson (J&J)
– Roche
– Eli Lilly
– Celgene

The report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments.

Visiongain’s study is intended for anyone requiring commercial analyses for the world cancer-treating drugs market. You find data, trends and predictions.

Buy our report today World Cancer-Treating Drugs Market Forecast 2017-2027: Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for World Cancer-Treating Drugs Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for World Cancer-Treating Drugs Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

READ

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Categories